Optic Nerve Compliance Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00328835 |
Recruitment Status :
Completed
First Posted : May 22, 2006
Last Update Posted : October 17, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Glaucoma | Procedure: Brief Elevation of IOP | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Enrollment : | 100 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Official Title: | Optic Nerve Compliance Study |
Study Start Date : | March 2006 |
Study Completion Date : | April 2006 |
- Optic Disc Change
- Visual Field Progression
- Visual Acuity Change

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Inclusion Criteria:
- Age over 18, Diagnosis of glaucoma (visual field proven), Stable, well controlled glaucoma
Exclusion Criteria:
- Previous eye surgery, Best corrected visual acuity <6/9, Chronic eye disease (including glaucoma, Secondary glaucoma (eg uveitis, neovascular glaucoma, etc), Advanced or fixation-threatening visual field changes, Ocular perfusion abnormalities (e.g. previous retinal artery or vein occlusion; or abnormal vasculature including those whose retinal circulation might be compromised by pressure on the eye).

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00328835
New Zealand | |
Capital Vision Research Trust | |
Wellington, New Zealand, 6001 |
Principal Investigator: | Anthony P Wells, FRANZCO | CVRT, Wellington School Of Medicine - University of Otago |
ClinicalTrials.gov Identifier: | NCT00328835 |
Other Study ID Numbers: |
ONCS |
First Posted: | May 22, 2006 Key Record Dates |
Last Update Posted: | October 17, 2006 |
Last Verified: | May 2006 |
Optic Nerve Glaucoma |
Glaucoma Ocular Hypertension Eye Diseases |